Amira Therapeutics SL has announced new preclinical findings for its lead compound AMI-463, which is being developed primarily for rhabdomyosarcoma, the most common soft tissue sarcoma in children.

Soft tissue sarcoma is metastatic if it has spread to areas in the body away from the location of the original tumor. Soft tissue sarcoma may spread through the bloodstream or lymphatic system to ...

Soft tissue sarcomas are cancers that develop in your body’s soft tissues like muscle, fat, tendons, or cartilage. Your legs are the most common place they develop. The American Cancer Society ...

Soft tissue injuries typically describe damage to muscles, tendons, and ligaments. They may lead to pain, swelling, and restricted mobility and can occur for many reasons. Some potential causes ...

Overall, soft tissue sarcoma has a positive 5-year survival rate. This can vary slightly according to age, sex, and treatment type. Soft tissue sarcoma is a general term used to describe cancers that ...